174 related articles for article (PubMed ID: 30324908)
21. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
22. CD95 Stimulation with CD95L and DISC Analysis.
Le Gallo M; Legembre P
Methods Mol Biol; 2017; 1557():11-18. PubMed ID: 28078578
[TBL] [Abstract][Full Text] [Related]
23. Asymmetry of intronic pre-miRNA structures in functional RISC assembly.
Lin SL; Chang D; Ying SY
Gene; 2005 Aug; 356():32-8. PubMed ID: 16005165
[TBL] [Abstract][Full Text] [Related]
24. The role of CD95 and CD95 ligand in cancer.
Peter ME; Hadji A; Murmann AE; Brockway S; Putzbach W; Pattanayak A; Ceppi P
Cell Death Differ; 2015 Apr; 22(4):549-59. PubMed ID: 25656654
[TBL] [Abstract][Full Text] [Related]
25. Death induced by CD95 or CD95 ligand elimination.
Hadji A; Ceppi P; Murmann AE; Brockway S; Pattanayak A; Bhinder B; Hau A; De Chant S; Parimi V; Kolesza P; Richards J; Chandel N; Djaballah H; Peter ME
Cell Rep; 2014 Apr; 7(1):208-22. PubMed ID: 24656822
[TBL] [Abstract][Full Text] [Related]
26. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
Sun X; Rogoff HA; Li CJ
Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
[TBL] [Abstract][Full Text] [Related]
27. Induction of DISE in ovarian cancer cells
Murmann AE; McMahon KM; Haluck-Kangas A; Ravindran N; Patel M; Law CY; Brockway S; Wei JJ; Thaxton CS; Peter ME
Oncotarget; 2017 Oct; 8(49):84643-84658. PubMed ID: 29156673
[TBL] [Abstract][Full Text] [Related]
28. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
Seyhan AA
Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
[TBL] [Abstract][Full Text] [Related]
29. Fas ligand released by activated monocytes causes apoptosis of lung epithelial cells in human acute lung injury model in vitro.
Mizuta M; Nakajima H; Mizuta N; Kitamura Y; Nakajima Y; Hashimoto S; Matsuyama H; Shime N; Amaya F; Koh H; Ishizaka A; Magae J; Tanuma SI; Hashimoto S
Biol Pharm Bull; 2008 Mar; 31(3):386-90. PubMed ID: 18310897
[TBL] [Abstract][Full Text] [Related]
30. [Detection of CD95 and CD95L mRNA expression after liver transplantation using SYBR real-time PCR during acute rejection].
Yu LX; Han SL; Miao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):185-8. PubMed ID: 16503525
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
[TBL] [Abstract][Full Text] [Related]
32. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
[TBL] [Abstract][Full Text] [Related]
33. CD95 signaling in cancer treatment.
De la Rosa AJ; Gomez MA; Morales S; Padillo FJ; Muntane J
Curr Pharm Des; 2014; 20(17):2809-18. PubMed ID: 23944368
[TBL] [Abstract][Full Text] [Related]
34. Nonapoptotic functions of Fas/CD95 in the immune response.
Guégan JP; Legembre P
FEBS J; 2018 Mar; 285(5):809-827. PubMed ID: 29032605
[TBL] [Abstract][Full Text] [Related]
35. Metalloprotease-mediated cleavage of CD95 ligand.
Risso V; Thomas M; Guével B; Lavigne R; Com E; Martin S; Nivet M; Pineau C; Negroni L; Lafont É; Chevet É; Eriksson LA; Le Gallo M
FEBS J; 2023 Jun; 290(12):3145-3164. PubMed ID: 36694998
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus virus-associated RNAII-derived small RNAs are efficiently incorporated into the rna-induced silencing complex and associate with polyribosomes.
Xu N; Segerman B; Zhou X; Akusjärvi G
J Virol; 2007 Oct; 81(19):10540-9. PubMed ID: 17652395
[TBL] [Abstract][Full Text] [Related]
37. Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells.
Weiss EM; Schmidt A; Vobis D; Garbi N; Lahl K; Mayer CT; Sparwasser T; Ludwig A; Suri-Payer E; Oberle N; Krammer PH
J Immunol; 2011 Aug; 187(4):1684-91. PubMed ID: 21746966
[TBL] [Abstract][Full Text] [Related]
38. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
[TBL] [Abstract][Full Text] [Related]
39. [Great potential of small RNAs: RNA interference and microRNA].
Vázquez-Ortiz G; Piña-Sánchez P; Salcedo M
Rev Invest Clin; 2006; 58(4):335-49. PubMed ID: 17146945
[TBL] [Abstract][Full Text] [Related]
40. Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs.
Lin SL; Ying SY
Methods Mol Biol; 2018; 1733():107-126. PubMed ID: 29435927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
